Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic Markers

NCT05541224 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT05541224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05541224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic Markers
Lead sponsor
PETHEMA Foundation
Phase
Observational
Overall status
Completed
Start date
November 1, 2019
Completion date
October 1, 2020
Enrollment
6,917 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia